Health Technologies and Regulation: Between Global Markets and Local Health Systems

Abstract

This panel explores the contentions of making, regulating and using health technologies in a world impacted by financialization, trade wars, supply chain disruptions, increasing distrust in expertise, and fiscal austerity. Health technologies are understood as pharmaceuticals, medical devices, diagnostics, digital and artificial intelligence (AI) apps, interventions or any other medical procedures. The papers ask, who are new technologies developed by? How do we know they are safe and effective? Who gets to use them? Contributions explore the governance of innovation, the politics of regulation, the tensions health technologies create within the health care state, and other related themes, advancing perspectives from political economy, regulatory politics, and science and technology studies.

Title	Details
Alternative Access Schemes as Hybrid Governance in European Pharmaceutical Regulation	View Paper Details
Silent Regulators and Noisy Firms	View Paper Details
From Entitlements to Interfaces : Health IDs, Data Governance and the Transformation of Citizenship in India	View Paper Details
Fusing the NHS: Digital Austerity and Infrastructural Dependence in the Remaking of the British Welfare State	View Paper Details
Governing High-Cost Health Technologies in a Universal Health System: Actors, Institutions, and Risk-Sharing in Brazil	View Paper Details